Home › Funds › COOPERMAN LEON G › KZIA
COOPERMAN LEON G position in KZIA
KAZIA THERAPEUTICS LTD · Health Care
COOPERMAN LEON G reported holding 50,000 shares of KZIA (KAZIA THERAPEUTICS LTD) in its Q3 2026 13F filing — a position valued at US$480K, representing 0.01% of its reported portfolio and ranking #40 among its reported holdings. COOPERMAN LEON G has disclosed KZIA holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How COOPERMAN LEON G's KZIA position evolved
COOPERMAN LEON G first disclosed a stake in KZIA in Q2 2026 at 50,000 shares (US$704K). Across 2 filings, COOPERMAN LEON G held the position steady without any share-count change. The most recent filing (Q3 2026) shows 50,000 shares valued at US$480K.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 50.00K | $704.00K | New |
| Q3 2026 | 50.00K | $479.75K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About KZIA and 13F data
KZIA (KAZIA THERAPEUTICS LTD) is a Health Care company. 56 other funds we track also report a position in KZIA — the largest reported positions include Boxer Capital Management, LLC (US$7.9M), Ikarian Capital, LLC (US$5.6M), Dauntless Investment Group, LLC (US$5.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding KZIA
- Boxer Capital Management, LLC 560.00K sh · $7.88M · Q2 2026
- Ikarian Capital, LLC 396.20K sh · $5.58M · Q2 2026
- Dauntless Investment Group, LLC 354.21K sh · $4.99M · Q2 2026
- Bleichroeder LP 490.41K sh · $4.71M · Q3 2026
- Stonepine Capital Management, LLC 377.43K sh · $3.62M · Q3 2026
- Kalehua Capital Management LLC 56.01K sh · $537.45K · Q3 2026
- ACT Capital Partners, L.P. 35.00K sh · $335.82K · Q3 2026
More on COOPERMAN LEON G
FAQ
How long has COOPERMAN LEON G held KZIA?
COOPERMAN LEON G has disclosed KZIA holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is COOPERMAN LEON G's current position in KZIA?
As of Q3 2026, COOPERMAN LEON G holds 50.00K shares of KZIA (KAZIA THERAPEUTICS LTD), valued at $479.75K, representing 0.01% of its reported portfolio and ranking #40.
Has COOPERMAN LEON G been buying or selling KZIA?
In the latest 13F filing (Q3 2026), COOPERMAN LEON G held unchanged its position in KZIA.
Which other funds hold KZIA?
Other major institutional holders of KZIA include Boxer Capital Management, LLC, Ikarian Capital, LLC, Dauntless Investment Group, LLC, among 56 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.